Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.39 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | ULK1 | O75385 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TNF | P01375 | 1/20 | 0.35 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17816446 | 0.80 | PDE4A (0.39) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL1536471 | 0.77 | LMNA (0.49) | LMNACYP3A4MAPTAPEX1MAPK1 | |
| SCHEMBL14924258 | 0.77 | PIK3CD (0.39) | PIK3CDLMNAMAPTKMT2AMEN1 | |
| SCHEMBL12337987 | 0.76 | SSTR4 (0.42) | CYP3A4MAPK1ULK1BACE1KMT2A | |
| SCHEMBL31696363 | 0.74 | LMNA (0.54) | LMNACYP3A4MAPTAPEX1MAPK1 | |
| SCHEMBL3146937 | 0.73 | CYP11B2 (0.43) | ULK1BACE1KMT2AMEN1KIF11 | |
| SCHEMBL13728229 | 0.73 | DYRK1A (0.40) | LMNAKMT2AMEN1POLBHPGD | |
| SCHEMBL20593890 | 0.72 | PDE4A (0.43) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL3141268 | 0.72 | PDE4A (0.43) | PDE4APDE4BPDE4CPDE4DLMNA | |
| SCHEMBL196720 | 0.72 | ALDH1A1 (0.55) | PDE4APDE4BPDE4CPDE4DLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1348711-B1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KK (JP) | 2018-06-13 | — | — | EP | disclosed |
| EP-1889891-B1 | Luminescence device and display apparatus | CANON KK (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-20150076478-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KK (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8920943-B2 | Luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2014-12-30 | — | — | US | disclosed |
| EP-1881050-B1 | Luminescence device and display apparatus | CANON KK (JP) | 2013-01-09 | — | — | EP | disclosed |
| US-7687155-B2 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2010-03-30 | — | — | US | disclosed |
| US-20090184634-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-07-23 | — | — | US | disclosed |
| US-7544426-B2 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7527879-B2 | Luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| CN-100375749-C | Luminescence device and display apparatus | CANON KK (JP) | 2008-03-19 | — | — | CN | disclosed |
| EP-1881050-A2 | Luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070216294-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070212570-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2007-09-13 | — | — | US | disclosed |
| US-7147935-B2 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2006-12-12 | — | — | US | disclosed |
| CN-1285601-C | Light emitting device and display | CANON KK (JP) | 2006-11-22 | — | — | CN | disclosed |
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2006-08-10 | — | — | US | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1474826-A | Light emitting device and display | ������������ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | AP3M1, MLEC, MLX | PIK3CD 2480/4885PDE4A 3881/4885PDE4B 3858/4885 |
| US-20090184634-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | SOD1, NLRP1, LUC7L2 | PIK3CD 2822/4885PDE4A 3932/4885PDE4B 3395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.